| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $334.3M | -16.0% |
| Cost of Revenue | $152.0M | -37.4% |
| Gross Profit | $182.3M | +17.5% |
| R&D Expense | $6.3M | -37.7% |
| SG&A Expense | $125.5M | -4.5% |
| Operating Income | -$67.8M | +48.2% |
| Pre-tax Income | -$29.6M | +71.0% |
| Income Tax | -$452K | +74.5% |
| Net Income | -$29.1M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $27.6M | -49.5% |
| Inventory | $69.1M | -24.3% |
| Current Assets | $477.1M | -31.7% |
| Total Assets | $685.7M | -26.2% |
| Current Liabilities | $68.2M | -40.7% |
| Total Liabilities | $633.9M | -27.1% |
| Stockholders' Equity | $51.8M | -12.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $16.1M | -25.8% |
| Capital Expenditures | $756K | -80.2% |
| Investing Cash Flow | -$6.8M | +78.4% |
| Financing Cash Flow | -$158.3M | -322.8% |
| Free Cash Flow | $15.4M | -14.2% |
| +70.9% |
| EPS (Basic) | -$0.23 | +69.7% |
| EPS (Diluted) | -$0.36 | +52.6% |